// App-Quantinova.ai

: Who Can Benefit from Adjuvant Transcatheter Arterial Chemoembolization after Surgical Resection of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis

Researchers

Presenter

  • L. Liang

Principal Investigators

  • C. Li

  • H. Xing

  • Y. Lau Wan

  • T.M. Pawlik

  • T. Yang

Medical Centers

  • Ohio State University Wexner Medical Center, United States

  • Chinese University of Hong Kong, Shatin, China

  • Eastern Hepatobiliary Surgery Hospital, China

  • Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, China

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

Disease

  • Liver cancer

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved